CNSP CNS Pharmaceuticals
CNS Pharmaceuticals earnings company data as of 4:48 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 13 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by CNSP's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $44K bought by 2 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Michal Fisher DirectorBuy$10K 2,000 shares at $5.00 New stakeTraded May 18 Filed Aug 18
-
Faith L. Charles DirectorBuy$34K 7,100 shares at $4.79 New stakeTraded May 18 Filed May 20
Also filed in the last 12 months, not counted as buying or selling: 1 option exercise.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| DEF 14A | DEFINITIVE NOTICE AND PROXY STATEMENT | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | FORM 10-Q FOR JUN 2026 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 424B3 | 424B3 PROSPECTUS | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | FORM 10-Q FOR MAR 2026 | Filing Doc | |
| 8-K | 1.01,3.02,5.02,9.01 | Filing Doc | |
| 10-K/A | AMENDMENT #1 TO FORM 10-K | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-K | FORM 10-K FOR DEC 2025 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 5.02,5.03,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | FORM 10-Q FOR SEP 2025 | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 424B5 | SUPPLEMENT NO. 3 TO PRO SUPP DATED 7-26-24 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.